Bessemer Securities LLC Eli Lilly & CO Transaction History

Bessemer Securities LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $306,463 - $422,506	705 New	705 $379,000
Q2 2020 Aug 12, 2020	SELL	$136.42 - $164.18 $1.5 Million - $1.81 Million	-11,016 Closed	0 $0
Q2 2019 Jul 19, 2019	BUY	$110.79 - $129.32 $1.22 Million - $1.42 Million	11,016 New	11,016 $1.22 Million

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $750B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Bessemer Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Bessemer Securities LLC with notifications on news.